These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1655071)

  • 21. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3H-imipramine binding in the blood platelets of normal twins.
    Arora RC; Meltzer HY
    Psychiatry Res; 1990 Jun; 32(3):265-73. PubMed ID: 2167491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1991 May; 29(10):1016-22. PubMed ID: 1648414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
    Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
    J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personality features and platelet 3H-imipramine binding.
    Castrogiovanni P; Maremmani I; Di Muro A; Rotondo A; Marazziti D
    Neuropsychobiology; 1992; 25(1):11-3. PubMed ID: 1318512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
    Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine.
    Marazziti D; Pfanner C; Palego L; Gemignani A; Milanfranchi A; Ravagli S; Lensi P; Presta S; Cassano GB
    Pharmacopsychiatry; 1997 Nov; 30(6):245-9. PubMed ID: 9442546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipramine binding in depressive patients diagnosed according to different criteria.
    Plenge P; Mellerup ET; Gjerris A
    Acta Psychiatr Scand; 1988 Aug; 78(2):156-61. PubMed ID: 2851919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of obsessive-compulsive disorder in Japan: a study of students using the Maudsley Obsessional-Compulsive Inventory and DSM-III-R.
    Tadai T; Nakamura M; Okazaki S; Nakajima T
    Psychiatry Clin Neurosci; 1995 Mar; 49(1):39-41. PubMed ID: 8608432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A longitudinal study of intact platelet 3H-imipramine binding in 12 normal human subjects.
    Goziotis A; Tang SW
    Psychiatry Res; 1988 Nov; 26(2):157-62. PubMed ID: 2853400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole blood serotonin in juvenile obsessive-compulsive disorder.
    Hanna GL; Yuwiler A; Cantwell DP
    Biol Psychiatry; 1991 Apr; 29(8):738-44. PubMed ID: 2054448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.